Antimicrobial

Basilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasis

Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…

3 months ago

Inbiome, developing a new PCR technology capable of simultaneous identification of hundreds of bacterial pathogens in a single test, welcomes Professor Dr. Carl Wittwer to its Advisory Board

Prof. Carl Wittwer Appointed in inbiome's Advisory Board Amsterdam, The Netherlands, September 20, 2024. Inbiome, a pioneer in advanced molecular diagnostics,…

3 months ago

Basilea enters into agreement with BARDA to develop novel antifungals and antibacterials and receives initial funding

Initial funding of USD 29 million to support development of Basilea’s clinical stage first-in-class antifungals, fosmanogepix and BAL2062Multi-year Other Transaction…

3 months ago

Nanocoatings Market Surges to USD 20.4 Billion by 2030, Propelled by 6.9% CAGR – Verified Market Reports®

The Nanocoatings market is driven by increasing demand across industries like automotive, electronics, and healthcare, where the coatings' enhanced durability,…

3 months ago

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”),…

3 months ago

Verily Sightline Expands Wastewater Testing Services to Europe Through Partnership with Bangor University in Wales

Exclusive partnership brings Verily’s innovative wastewater surveillance technology to the United Kingdom DALLAS--(BUSINESS WIRE)--Today, Verily, a precision health technology company,…

3 months ago

Aspen Dental: Caring for Dental Implants: Maintenance Tips and Common Issues

NEW YORK, NY / ACCESSWIRE / September 16, 2024 / Dental implants are one of the most expensive procedures, but…

3 months ago

F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US

Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and…

3 months ago

Leidos awarded CDC’s National Health Safety Network modernization contract

RESTON, Va., Sept. 3, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune® 500 innovation company, was recently awarded the National Healthcare Safety Network (NHSN)…

4 months ago